Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-2.00%
1,044.85
-21.36
-2.00%
—1,066.211,064.941,064.941,038.77——
SIXC
Communications
SIXC
Communications
SIXC
-0.91%
605.59
-5.57
-0.91%
—611.16611.16612.25605.36——
SIXE
Energy
SIXE
Energy
SIXE
+0.50%
1,276.24
+6.31
+0.50%
—1,269.931,273.161,276.691,262.69——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.04%
1,702.58
-17.83
-1.04%
—1,720.411,717.391,717.391,694.47——
SIXM
Financials
SIXM
Financials
SIXM
-0.45%
634.24
-2.89
-0.45%
—637.13637.40637.74631.77——
SIXR
Staples
SIXR
Staples
SIXR
+0.49%
870.51
+4.26
+0.49%
—866.25865.77874.12858.72——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.45%
215.60
+0.96
+0.45%
—214.64214.64215.60213.49——
SIXT
Technology
SIXT
Technology
SIXT
-1.12%
3,470.82
-39.42
-1.12%
—3,511.133,481.073,527.593,440.20——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.83%
894.24
+7.32
+0.83%
—886.92885.23894.65881.74——
SIXV
Health care
SIXV
Health care
SIXV
+1.26%
1,488.96
+18.47
+1.26%
—1,470.491,470.681,494.421,462.16——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.66%
2,310.67
-39.10
-1.66%
—2,349.772,332.172,332.172,307.43——
PLRX:NASDAQ
Pliant Therapeutics Inc
$1.16
-1.27%
(-0.015) 1D
May 19, 12:24:40 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PLRX...
Open
$1.19
High
$1.19
Low
$1.16
Mkt. cap
72.45M
Avg. vol.
466.11K
Volume
234.55K
52-wk high
$1.95
52-wk low
$1.09
EPS
-$1.84
Beta
1.20
Shares outstanding
61.92M
No. of employees
49
News stories
From sources across the web
About Pliant Therapeutics Inc
CEO-
Employees49
Founded2015
HeadquartersSouth San Francisco, California, United States
SectorPharmaceutical industry
Websitepliantrx.com
Last report
May 11, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
-$0.32 / -$0.36
+10.60%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
32.20M
17.84M
13.38M
13.58M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.39M
10.33M
7.69M
8.19M
Operating expense
45.59M
28.17M
21.08M
21.77M
Total operating expenses
45.59M
28.17M
21.08M
21.77M
Operating income
-45.59M
-28.17M
-21.08M
-21.77M
Other non operating income
-
-
-
-
EBT including unusual items
-43.30M
-26.30M
-23.58M
-20.04M
EBT excluding unusual items
-43.30M
-26.20M
-19.25M
-20.04M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-43.30M
-26.30M
-23.58M
-20.04M
Net profit margin
-
-
-
-
Earnings per share
-0.71
-0.43
-0.35
-0.32
Interest and investment income
3.10M
2.78M
1.96M
1.73M
Interest expense
-809.00K
-815.00K
-136.00K
-
Net interest expenses
2.29M
1.97M
1.83M
1.73M
Depreciation and amortization charges
-
-
-
-
EBITDA
-45.14M
-27.73M
-20.71M
-21.51M
Gain or loss from assets sale
-
-44.00K
-
-94.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer